       Document 0067
 DOCN  M9640067
 TI    Structure-based design of sulfonamide-substituted non-peptidic HIV
       protease inhibitors.
 DT    9604
 AU    Skulnick HI; Johnson PD; Howe WJ; Tomich PK; Chong KT; Watenpaugh KD;
       Janakiraman MN; Dolak LA; McGrath JP; Lynn JC; et al; Upjohn
       Laboratories, Kalamazoo, Michigan 49001, USA.
 SO    J Med Chem. 1995 Dec 22;38(26):4968-71. Unique Identifier : AIDSLINE
       MED/96130342
 DE    Animal  Antiviral Agents/CHEMISTRY/PHARMACOLOGY/PHARMACOKINETICS  Dogs
       *Drug Design  Hydrogen Bonding  HIV/*DRUG EFFECTS  HIV
       Protease/METABOLISM  HIV Protease
       Inhibitors/*CHEMISTRY/*PHARMACOLOGY/PHARMACOKINETICS  HIV-1/DRUG
       EFFECTS/ENZYMOLOGY  HIV-2/DRUG EFFECTS/ENZYMOLOGY  Models, Molecular
       Monte Carlo Method
       Pyrones/*CHEMISTRY/METABOLISM/*PHARMACOLOGY/PHARMACOKINETICS  Rats
       Sulfonamides/*CHEMISTRY/METABOLISM/*PHARMACOLOGY/PHARMACOKINETICS
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

